Philip Tsai
Vermögen: 945 239 $ am 31.05.2026
Vermögen: 945 239 $ am 31.05.2026
Philip Tsai currently works at Immunome, Inc., as Chief Technical Officer from 2024.
Dr. Tsai also formerly worked at Seagen, Inc., as Senior Vice President-Technical Development from 2021 to 2024.
Dr. Tsai received his graduate degree and doctorate degree from California Institute of Technology and undergraduate degree from the University of Illinois At Urbana–Champaign.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOME, INC. 0,04 % | 19.12.2025 | 43.300 ( 0,04 % ) | 945 239 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOME, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.06.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| SEAGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2024 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois At Urbana–Champaign
University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen